Article | May 16, 2017

Are You Prepared To Replace The Thorough QT Study?

Source: ERT

Robert Kleiman, MD, Chief Medical Officer and Vice President, Global Cardiology, ERT

Regulatory bodies have adopted the 2005 ICH E14 guidance to mandate the evaluation of a new drug’s effect on QTc in a formal Thorough QT (TQT) trial for cardiac safety issues. The updated release to the ICH E14 Guidance could indicate that data be used to replace a TQT trial for regulatory submission and review. Learn more about how planning ahead can save time and money later for some clinical trials.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)